Projecting the future diabetes population size and related costs for the U.S

Elbert S Huang, Anirban Basu, Michael O'Grady, James C Capretta, Elbert S Huang, Anirban Basu, Michael O'Grady, James C Capretta

Abstract

Objective: We developed a novel population-level model for projecting future direct spending on diabetes. The model can be used in the federal budget process to estimate the cost implications of alternative policies.

Research design and methods: We constructed a Markov model simulating individuals' movement across different BMI categories, the incidence of diabetes and screening, and the natural history of diabetes and its complications over the next 25 years. Prevalence and incidence of obesity and diabetes and the direct spending on diabetes care and complications are projected. The study population is 24- to 85-year-old patients characterized by the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey and National Health Interview Survey.

Results: Between 2009 and 2034, the number of people with diagnosed and undiagnosed diabetes will increase from 23.7 million to 44.1 million. The obesity distribution in the population without diabetes will remain stable over time with approximately 65% of individuals of the population being overweight or obese. During the same period, annual diabetes-related spending is expected to increase from $113 billion to $336 billion (2007 dollars). For the Medicare-eligible population, the diabetes population is expected to rise from 8.2 million in 2009 to 14.6 million in 2034; associated spending is estimated to rise from $45 billion to $171 billion.

Conclusions: The diabetes population and the related costs are expected to at least double in the next 25 years. Without significant changes in public or private strategies, this population and cost growth are expected to add a significant strain to an overburdened health care system.

Figures

Figure 1
Figure 1
Conceptual model of costs of diabetes with prevalent and future cohorts over time.
Figure 2
Figure 2
Projected distribution of newly diagnosed, undiagnosed, and established cases of diabetes, 2009–2034.
Figure 3
Figure 3
Projected direct spending on diabetes and its complications for different cohorts, 2008–2033. Reprinted with permission from Huang et al. (23).

References

    1. DeVol R, Bedroussian A: An Unhealthy America: The Economic Burden of Chronic Disease Santa Monica, California, Milken Institute, 2007
    1. Helms RB: Implications of population growth on prevalence of diabetes: a look at the future. Diabetes Care 1992; 15 ( Suppl. 1): 6– 9
    1. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414– 1431
    1. Boyle JP, Honeycutt AA, Narayan KM, et al. : Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001; 24: 1936– 1940
    1. Incidence of diabetes in the population aged 18–79 years [Internet], Atlanta, Georgia, Centers for Disease Control and Prevention. Available from Accessed 20 April 2008
    1. Clarke PM, Gray AM, Briggs A, et al. : A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004; 47: 1747– 1759
    1. Stevens RJ, Kothari V, Adler AI, et al. : The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671– 679
    1. Kothari V, Stevens RJ, Adler AI, et al. : UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002; 33: 1776– 1781
    1. The Mount Hood 4 Modeling Group. Computer modeling of diabetes and its complications. Diabetes Care 2007; 30: 1638– 1646
    1. Huang ES, Zhang Q, Brown SE, et al. : The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers. Health Serv Res 2007; 42: 2174– 2193
    1. Eastman RC, Javitt JC, Herman WH, et al. : Model of complications of NIDDM. Model construction and assumptions. Diabetes Care 1997; 20: 725– 734
    1. Humphrey LL, Ballard DJ, Frohnert PP, et al. : Chronic renal failure in non-insulin-dependent diabetes mellitus: a population-based study in Rochester, Minnesota. Ann Intern Med 1989; 111: 788– 796
    1. Andersen R, DeTurk P: National Vital Statistics Report Hyattesville, MD, National Center for Health Statistics, 2002
    1. Petty GW, Brown RD, Jr, Whisnant JP, et al. : Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975–1989. Neurology 1998; 50: 208– 216
    1. U.S. Renal Data System. USRDS 1994 Annual Data Report: Appendix D17 Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1994
    1. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 1999; 355: 253– 259
    1. Hansson L, Zanchetti A, Carruthers SG, et al. : Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial: HOT Study Group. Lancet 1998; 351: 1755– 1762
    1. Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. J Am Med Assoc 2005; 293: 217– 228
    1. Saydah SH, Fradkin JE, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291: 335– 342
    1. Cohen FJ, Neslusan CA, Conklin JE, et al. : Recent antihyperglycemic prescribing trends for U.S. privately insured patients with type 2 diabetes. Diabetes Care 2003; 26: 1847– 1851
    1. Saaddine JB, Cadwell B, Gregg EW, et al. : Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med 2006; 144: 465– 474
    1. Chin MH, Drum ML, Guillen M, et al. : Improving and sustaining diabetes care in community health centers with the health disparities collaboratives. Med Care 2007; 45: 1135– 1143
    1. Huang ES, Basu A, Capretta JC, et al. : Federal cost estimates: a look at how a clinically-driven projection model for diabetes could inform budget estimates and decisions. Health Affairs 2009; 28: w978– w990
    1. Homer J, Milstein B, Dietz W, et al. : Obesity population dynamics: exploring historical growth and plausible futures in the U.S. In 24th International Conference of the System Dynamics Society.Nijmegen, the Netherlands, 2006
    1. Davidson MB: The disproportionate burden of diabetes in African-American and Hispanic populations. Ethn Dis 2001; 11: 148– 151

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren